Impaired p53 Expression, Function, and Nuclear Localization in Calreticullum-deficient Cells

Molecular Biology of the Cell

Volumn 15, Issue 4, 2004, Pages 1862-1870

  Mesaeli, Nasrin ^a   Phillipson, Clark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; IMMUNOCYTOCHEMISTRY; MITOSIS INHIBITION; MOUSE; MURINE DOUBLE MINUTE GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; BINDING SITES; BLOTTING, WESTERN; CALRETICULIN; CELL NUCLEUS; DNA DAMAGE; FIBROBLASTS; GENES, REPORTER; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MODELS, GENETIC; NUCLEAR PROTEINS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA; MURINAE;

EID: 1642546248     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-04-0251     Document Type: Article

References (53)

1. Ashcroft, M., Taya, Y., and Vousden, K.H. (2000). Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 20, 3224-3233.
2. Ashcroft, M., and Vousden, K.H. (1999). Regulation of p53 stability. Oncogene 18, 7637-7643.
3. Bastianutto, C., Clementi, E., Codazzi, F., Podini, P., De Giorgi, F., Rizzuto, R., Meldolesi, J., and Pozzan, T. (1995). Overexpression of calreticulin increases the Ca2+ capacity of rapidly exchanging Ca2+ stores and reveals aspects of their lumenal microenvironment and function. J. Cell Biol. 130, 847-855.
4. Bellamy, C.O., Prost, S., Wyllie, A.H., and Harrison, D.J. (1997). UV but not gamma-irradiation induces specific transcriptional activity of p53 in primary hepatocytes. J. Pathol. 183, 177-181.
5. Camacho, P., and Lechleiter, J.D. (1995). Calreficulin inhibits repetitive intracellular Ca2+ waves. Cell 82, 765-771.
6. Chen, J., Lin, J., and Levine, A.J. (1995). Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1, 142-152.
7. Coppolino, M.G., Woodside, M.J., Demaurex, N., Grinstein, S., St-Arnaud, R., and Dedhar, S. (1997). Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 386, 843-847.
8. Cotton, J., and Spandau, D.F. (1997). Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes. Radiat. Res. 147, 148-155.
9. Dang, C.V., and Lee, W.M. (1989). Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J. Biol. Chem. 264, 18019-18023.
10. Donehower, L.A. (1996). The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol. 7, 269-278.
11. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
12. Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H., and Weissman, A.M. (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8951.
13. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
14. Hebert, D.N., Zhang, J.X., Chen, W., Foellmer, B., and Helenius, A. (1997). The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Biol. 139, 613-623.
15. Holaska, J.M., Black, B.E., Love, D.C., Hanover, J.A., Leszyk, J., and Paschal, B.M. (2001). Calreticulin is a receptor for nuclear export. J. Cell Biol. 152, 127-140.
16. Holaska, J.M., Black, B.E., Rastinejad, F., and Paschal, B.M. (2002). Ca-dependent nuclear export mediated by calretciulin. Mol. Cell. Biol. 22, 6286-6297.
17. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. (1991). p53 mutations in human cancers. Science 253, 49-53.
18. Honda, R., Tanaka, H., and Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27.
19. Inoue, T., Geyer, R.K., Howard, D., Yu, Z.K., and Maki, C.G. (2001). MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding. J. Biol. Chem. 276, 45255-45260.
20. Kageyama, K., Ihara, Y., Goto, S., Urata, Y., Toda, G., Yano, K., and Kondo, T. (2002). Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J. Biol. Chem. 277, 19255-19264.
21. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
22. Lain, S., Midgley, C., Sparks, A., Lane, E.B., and Lane, D.P. (1999a). An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp. Cell Res. 248, 457-472.
23. Lain, S., Xirodimas, D., and Lane, D.P. (1999b). Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function. Exp. Cell Res. 253, 315-324.
24. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
25. Li, J., Puceat, M., Perez-Terzic, C., Mery, A., Nakamura, K., Michalak, M., Krause, K.H., and Jaconi, M.E. (2002). Calreticulin reveals a critical Ca(2+) checkpoint in cardiac myofibrillogenesis. J. Cell Biol. 158, 103-113.
26. Liu, M., and Pelling, J.C. (1995). UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene 10, 1955-1960.
27. Liu, N., Fine, R.E., Simons, E., and Johnson, R.J. (1994). Decreasing calreticulin expression lowers the Ca2+ response to bradykinin and increases sensitivity to ionomycin in NG-108-15 cells. J. Biol. Chem. 269, 28635-28639.
28. Lohrum, M.A., Woods, D.B., Ludwig, R.L., Balint, E., and Vousden, K.H. (2001). C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 21, 8521-8532.
29. Mayo, L.D., Dixon, J.E., Durden, D.L., Tonks, N.K., and Donner, D.B. (2002). PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277, 5484-5489.
30. Mayo, L.D., and Donner, D.B. (2001). A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. USA 98, 11598-11603.
31. Mery, L., Mesaeli, N., Michalak, M., Opas, M., Lew, D.P., and Krause, K.H. (1996). Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx. J. Biol. Chem. 271, 9332-9339.
32. Mesaeli, N., Nakamura, K., Zvaritch, E., Dickie, P., Dziak, E., Krause, K.H., Opas, M., MacLennan, D.H., and Michalak, M. (1999). Calreticulin is essential for cardiac development. J. Cell Biol. 144, 857-868.
33. Michalak, M., Corbett, E.F., Mesaeli, N., Nakamura, K., and Opas, M. (1999). Calreticulin: one protein, one gene, many functions [In Process Citation]. Biochem. J. 344(Pt 2), 281-292.
34. Middeler, G., Zerf, K., Jenovai, S., Thulig, A., Tschodrich-Rotter, M., Kubitscheck, U., and Peters, R. (1997). The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14, 1407-1417.
35. Momand, J., Zambetti, G.P., Olson, D.C., George, D., and Levine, A.J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245.
36. Nakamura, K. et al. (2000). Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis. J. Cell Biol. 150, 731-740.
37. Nauseef, W.M., McCormick, S.J., and Clark, R.A. (1995). Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J. Biol. Chem. 270, 4741-4747.
38. Nigam, S.K., Goldberg, A.L., Ho, S., Rohde, M.F., Bush, K.T., and Sherman, M. (1994). A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. J. Biol. Chem. 269, 1744-1749.
39. Reich, N.C., and Levine, A.J. (1984). Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308, 199-201.
40. Reinke, V., and Lozano, G. (1997). Differential activation of p53 targets in cells treated with ultraviolet radiation that undergo both apoptosis and growth arrest. Radiat. Res. 148, 115-122.
41. Rotter, V., Abutbul, H., and Ben-Ze'ev, A. (1983). P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts. EMBO J. 2, 1041-1047.
42. Rubbi, C.P., and Milner, J. (2000). Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus. Oncogene 19, 85-96.
43. Saucedo, L.J., Carstens, B.P., Seavey, S.E., Albee, L.D., 2nd, and Perry, M.E. (1998). Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation. Cell Growth Differ. 9, 119-130.
44. Schlamp, C.L., Poulsen, G.L., Nork, T.M., and Nickells, R.W. (1997). Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells [see comments]. J. Natl. Cancer Inst. 89, 1530-1536.
45. Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., and Rotter, V. (1990). Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10, 6565-6577.
46. Stommel, J.M., Marchenko, N.D., Jimenez, G.S., Moll, U.M., Hope, T.J., and Wahl, G.M. (1999). A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672.
47. Tao, W., and Levine, A.J. (1999). Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. USA 96, 3077-3080.
48. Wadgaonkar, R., and Collins, T. (1999). Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression. J. Biol. Chem. 274, 13760-13767.
49. Waser, M., Mesaeli, N., Spencer, C., and Michalak, M. (1997). Regulation of calreticulin gene expression by calcium. J. Cell Biol. 138, 547-557.
50. Woods, D.B., and Vousden, K.H. (2001). Regulation of p53 function. Exp. Cell Res. 264, 56-66.
51. Wu, L., and Levine, A.J. (1997). Differential regulation of the p21/ WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene. Mol. Med. 3, 441-451.
52. Yu, Z.K., Geyer, R.K., and Maki, C.G. (2000). MDM2-dependent ubiquitination of nuclear and cytoplasmic P53. Oncogene 19, 5892-5897.
53. Zhang, Y., and Xiong, Y. (2001). A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292, 1910-1915.